Skip to main content
HR 913 116th Congress House Health Cancer Drug therapy Government studies and investigations Health care costs and insurance Medicaid Medical research Research administration and funding

CLINICAL TREATMENT Act

Introduced: January 30, 2019 Introduced by: Luján, Ben Ray Democratic · New Mexico See on congress.gov
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 30, 2019
Referred to the House Committee on Energy and Commerce.
Jan 30, 2019
Introduced in House
 Plain-English summary Congressional Research Service

Covering Life-saving Investigations Needed in Cancer and Other Life-threatening Conditions through Timely use of Resources for Easy and Affordable Treatment from Medicaid for Enrollees in Need Today Act or the CLINICAL TREATMENT Act

This bill requires state Medicaid programs to cover routine patient costs for items and services that are provided in connection with a qualifying clinical trial regarding cancer or other life-threatening conditions.

The bill defines "routine patient costs" to include items and services that would otherwise be covered under Medicaid absent the patient's participation in the clinical trial; the term includes items and services relating to trial complications, but excludes those items and services that are the subject of the trial or that are provided solely in relation to data analysis.

Additionally, a "qualifying clinical trial" means, among other things, a clinical trial that is approved or funded by specified entities (e.g., the National Institutes of Health) or is an authorized new drug trial.

What's happening now January 30, 2019

Referred to the House Committee on Energy and Commerce.

 Committees of jurisdiction 1
 Cosponsors 34